1Ferndndez M, Alarcon GS, Apte M, et al. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thromboeytopenia as a prognostic factor [J]. Arthritis Rheum,2007,56(2):614-621.
2Asmussen K, Andersen V, Bendixen G, et al. A new model for classification of disease manifestations in primary Sjogren's syndrome:evaluation in a retrospective long-term study[J]. J Interm Med, 1996,239 (6) : 475-482.
3Ziakas PD,Routsias JG,Giannouli S,et al. Suspects in the tale of lupus-associated thrombocytopenia [J]. Clin Exp Immunol, 2006,145(1):71-80.
5Aranow C, del Guidice J, Barland P, et al. Systemic lupus erythematosus disease severity in men and women: a casecontrol study[J]. J Rheumatol, 2002,29 (8) : 1674-1677.
6Higashi K, Matsuki Y, Hidaka T, et al. Primary Sjogren's syndrome associated with hyaline-vascular type of Castleman's disease and autoimmune idiopathic thrombocytopenia[J]. Stand J Rheumatol,1997,26(6) :482-484.
7Klepfish A, Friedman J, Schechter Y, et al. Autoimmune neutropenia, thrombocytopenia and Coombs positivity in a patient with primary Sjogren's syndrome [J]. Rheumatology, 2001,40(8) :948-949.
